Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report)'s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $57.33 and traded as low as $57.05. Utah Medical Products shares last traded at $57.59, with a volume of 15,951 shares changing hands.
Utah Medical Products Stock Down 0.1%
The stock has a fifty day simple moving average of $55.20 and a 200 day simple moving average of $57.33. The firm has a market capitalization of $185.93 million, a P/E ratio of 15.13 and a beta of 0.28.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last issued its earnings results on Tuesday, April 29th. The medical instruments supplier reported $0.92 earnings per share for the quarter. Utah Medical Products had a net margin of 33.00% and a return on equity of 10.74%. The firm had revenue of $9.71 million during the quarter.
Utah Medical Products Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, July 3rd. Stockholders of record on Monday, June 16th were issued a dividend of $0.305 per share. The ex-dividend date was Monday, June 16th. This represents a $1.22 annualized dividend and a dividend yield of 2.13%. Utah Medical Products's dividend payout ratio (DPR) is 32.28%.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of UTMD. Charles Schwab Investment Management Inc. grew its stake in shares of Utah Medical Products by 8.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 10,431 shares of the medical instruments supplier's stock valued at $641,000 after buying an additional 813 shares during the last quarter. Atria Investments Inc boosted its holdings in shares of Utah Medical Products by 23.8% in the fourth quarter. Atria Investments Inc now owns 8,899 shares of the medical instruments supplier's stock valued at $547,000 after purchasing an additional 1,712 shares during the period. Brandes Investment Partners LP grew its stake in Utah Medical Products by 17.8% in the fourth quarter. Brandes Investment Partners LP now owns 162,969 shares of the medical instruments supplier's stock worth $10,018,000 after purchasing an additional 24,604 shares in the last quarter. Royce & Associates LP grew its stake in Utah Medical Products by 159.0% in the fourth quarter. Royce & Associates LP now owns 41,958 shares of the medical instruments supplier's stock worth $2,579,000 after purchasing an additional 25,755 shares in the last quarter. Finally, American Century Companies Inc. grew its stake in Utah Medical Products by 8.6% in the fourth quarter. American Century Companies Inc. now owns 8,135 shares of the medical instruments supplier's stock worth $500,000 after purchasing an additional 643 shares in the last quarter. Institutional investors own 69.60% of the company's stock.
About Utah Medical Products
(
Get Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Featured Stories
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
